1. Home
  2. Stock quotes
  3. 4D Molecular Therapeutics
  4. Financial Ratios
  5. EV/EBITDA Ratio
4D Molecular Therapeutics logo
4D Molecular Therapeutics FDMT
$ 6.27 8.47%
mail-toReport an Error

Quarterly report 2024-Q3
added 11-13-2024

report update icon

4D Molecular Therapeutics EV/EBITDA Ratio 2011-2024 | FDMT

Annual EV/EBITDA Ratio 4D Molecular Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-3.46 -4.59 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-3.46 -4.59 -4.03